share_log

A股基因检测概念拉升,冠昊生物涨停

The concept of genetic testing in A-shares is rising, and Guanhao Biotech has hit the limit.

Gelonghui Finance ·  Sep 9 09:55

Guanhao Biotech hit the limit up, Vcanbio Cell & Gene Engineering Corp.,Ltd. closed at the limit, Canature Health Technology, Nanjing Xinjiekou Department Store, Tellgen Corporation, Xi'an International Medical Investment all saw significant volume increase.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment